-       Report 
- January 2024
-  200 Pages 
- Global 
   From       €3693EUR$4,150USD£3,251GBP 
          -       Report 
- October 2023
-  145 Pages 
- Global 
   From       €2803EUR$3,150USD£2,467GBP 
            -       Report 
- July 2024
-  150 Pages 
- Global 
   From       €2670EUR$3,000USD£2,350GBP 
      €3337EUR$3,750USD£2,937GBP 
            -       Report 
- June 2024
-  200 Pages 
- Global 
   From       €5660EUR$6,360USD£4,982GBP 
      €7074EUR$7,950USD£6,227GBP 
            -       Report 
- May 2024
-  298 Pages 
- Global 
   From       €5660EUR$6,360USD£4,982GBP 
      €7074EUR$7,950USD£6,227GBP 
             -       Report 
- February 2024
-  245 Pages 
- Global 
   From       €5660EUR$6,360USD£4,982GBP 
      €7074EUR$7,950USD£6,227GBP 
            -       Report 
- May 2023
-  220 Pages 
- Global 
   From       €1780EUR$2,000USD£1,567GBP 
      €2225EUR$2,500USD£1,958GBP 
            -       Report 
- May 2023
-  450 Pages 
- Global 
   From       €3559EUR$4,000USD£3,133GBP 
      €4449EUR$5,000USD£3,917GBP 
            -       Report 
- April 2023
-  350 Pages 
- Global 
   From       €2314EUR$2,600USD£2,037GBP 
      €2892EUR$3,250USD£2,546GBP 
            -       Drug Pipelines 
- December 2022
-  30 Pages 
- Global 
   From       €2314EUR$2,600USD£2,037GBP 
      €2892EUR$3,250USD£2,546GBP 
            -       Report 
- September 2022
-  239 Pages 
- Global 
   From       €5339EUR$6,000USD£4,700GBP 
      €6674EUR$7,500USD£5,875GBP 
            -       Report 
- August 2022
-  151 Pages 
- Global 
   From       €6763EUR$7,600USD£5,953GBP 
      €8454EUR$9,500USD£7,441GBP 
            -       Report 
- February 2021
-  50 Pages 
- Global 
   From       €2314EUR$2,600USD£2,037GBP 
      €2892EUR$3,250USD£2,546GBP 
            -       Report 
- April 2020
-  80 Pages 
- Global 
   From       €2812EUR$3,160USD£2,475GBP 
      €3515EUR$3,950USD£3,094GBP 
          -       Report 
- July 2024
-  200 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  120 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  70 Pages 
- Europe 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- April 2023
-  119 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
            -       Report 
- September 2022
-  247 Pages 
- Global 
   From       €2336EUR$2,625USD£2,056GBP 
      €4672EUR$5,250USD£4,112GBP 
            -       Report 
- May 2024
-  138 Pages 
- Global 
   From       €4916EUR$5,524USD£4,327GBP 
      €5783EUR$6,499USD£5,091GBP 
       
      Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is    also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less   Read more